Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

HistoRx, Inc

HistoRx is a bioscience company applying quantitative tools of molecular and cellular biology to develop new tools for pathology.HistoRx has introduced the first tissue-based quantitative molecular assessment tool for pathology. The revolutionary AQUA™ Platform for Quantitative Pathology replaces the DAB-based automated systems and the traditional, subjective approach of manually analyzing tissue according to observable morphological patterns with a robust, high-throughput, highly quantitative technology platform capable of unlocking critical knowledge about proteins in activated cell signaling pathways. The AQUA™ platform dramatically improves the accuracy and speed of analysis while reducing error through objective, rigorous measurement of protein expression that delivers advanced information about the molecular biology of diseased tissue, empowering researchers and clinicians involved in molecular-based drug discovery, disease detection and diagnosis, clinical pathology, and patient care.


Contact Details:
300 George Street
New Haven
Connecticut
06511
United States of America
Tel:203-498-7500
Fax:203-498-7501
Email:info@historx.com
WWW:

www.historx.com/




Loading...

Press Releases on HistoRx, Inc:

BioPortfolio Logo
AQUA(R) Technology Recognized as 'Promising New Strategy' for Hormone Receptor Testing in Breast Cancer by NCCN Task Force 17th November, 2009 HistoRx, Inc.
NEW HAVEN, Conn., Nov. 17 /PRNewswire/ -- HistoRx today announced that the Company's proprietary AQUA technology, an automated image analysis platform based on tissue-based quantitative
HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations 17th July, 2008 HistoRx, Inc.
NEW HAVEN, Conn., July 17 /PRNewswire/ -- HistoRx, Inc., announced today that William C. Sullivan has joined the company as Senior Vice President, Diagnostic Operations. In this newly created

BioNews Results for HistoRx, Inc:

Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Ralcorp Holdings Inc, Aqua America Inc, MetroPCS C
Guru Focus:  Nov 16 2009 3:51AM Matching: inc
AngioDynamics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 5:28AM Matching: inc
Alcon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 6:25AM Matching: inc
Antares Pharma, Inc. - Medical Equipment - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 5:23AM Matching: inc
Antares Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 5:23AM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution

View more HistoRx, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 389 times since April 2007, the link to the organisation's website has been followed 59 times

Recent Search Terms used to find this page: historx | .

Search for more companies in New Haven

Search for more companies in Connecticut



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for HistoRx, Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.